Regor’s leading rCARD™ platform empowers drug discovery and development from target identification and validation, molecular design and optimization, to translational research and clinical development ...
Join us for a webinar on how advances in target-based drug discovery are reshaping therapeutic design. We’ll explore ...
LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. (www.maxbiopharma.com) and Revilico, Inc. (www.revilico.bio) announced their collaboration in studying the mechanisms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback